A recent study showed that both cognitive behavioral therapy (CBT) and the mild stimulant modafinil (Provigil) reduced MS ...

Oct. 2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...

In a study of commonly used treatments for people with multiple sclerosis, both medical and behavioral interventions, and a ...

Multiple sclerosis (MS) is a disease of the central nervous system that causes damage to your brain, spinal cord, and optic nerves. It’s characterized by lesions, or areas of tissue damage that ...

The COMBO-MS trial, reported in The Lancet Neurology by Tiffany Braley and colleagues,1 is the first pragmatic, randomised, controlled trial that compares head-to-head the benefits and harms of a ...

The following is a summary of “Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort ...

Multiple sclerosis (MS) is a chronic autoimmune disease where the immune system attacks the myelin sheath, a protective covering around nerves in the brain and spinal cord. This causes damage that ...

Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics ...

Denali Therapeutics said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to ...

Exercise can be a challenge for some people with multiple sclerosis (MS). Muscle weakness, numbness, and balance issues can make physical activity difficult. Still, exercise is important for ...

The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease. Multiple sclerosis occurs when the body ...

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers say ...